Low-Dose Anticoagulation for Secondary Prevention in Acute Coronary Syndrome
After acute coronary syndrome (ACS), long-term dual antiplatelet therapy with acetylsalicylic acid and a P2Y 12 platelet receptor antagonist is the standard of care for secondary prevention. Despite the introduction…